Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Auditor

4 Oct 2022 15:30

RNS Number : 7583B
Maven Income & Growth VCT PLC
04 October 2022
 

MAVEN INCOME AND GROWTH VCT PLC (Maven VCT), MAVEN INCOME AND GROWTH VCT 3 PLC (Maven VCT 3), MAVEN INCOME AND GROWTH VCT 4 PLC (Maven VCT 4), and MAVEN INCOME AND GROWTH VCT 5 PLC (Maven VCT 5); (each a Company and together the Companies) 

Change of Auditor

Following a formal tender process, the Companies are pleased to announce the appointment of Johnston Carmichael LLP (Johnston Carmichael) as its new Auditor with effect from 4 October 2022. Johnston Carmichael will conduct the audit of each Company's financial statements for their current financial years, which are to 30 November 2022 for Maven VCT 3 and Maven VCT 5; 31 December 2022 for Maven VCT 4; and 28 February 2023 for Maven VCT. The appointment of Johnston Carmichael as Auditor for each Company's subsequent financial year will be subject to approval by Shareholders at their next respective Annual General Meetings, all to be held in 2023.

In accordance with Section 519 of the Companies Act 2006, the Company's previous Auditor, Deloitte LLP (Deloitte), has deposited a statement with each of the Companies of the circumstances connected with them ceasing to hold office as Auditor of the Companies (the Statement). Each Statement confirms that Deloitte resigned as Auditor of the relevant Company because they considered that the fee was uneconomic, given the effort required to conduct the audit. Copies of the Statements will be sent to every person who is entitled to receive a copy of each Company's Annual Reports and Financial Statements.

The Boards of the Companies wish to take this opportunity to extend their appreciation and gratitude to Deloitte for the services rendered to the Companies during its respective periods of tenure.

Issued on behalf of the Companies

Maven Capital Partners UK LLP, Secretary

4 October 2022

Enquiries: 

Graeme Cullen, Maven Capital Partners UK LLP:

Tel: +44 (0) 141 206 0110

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPGBPUUPPGCC
Date   Source Headline
3rd Mar 20217:00 amRNSIssue of Equity
24th Feb 20214:41 pmRNSTransaction in Own Shares
16th Feb 20217:00 amRNSNet Asset Value and Proposed Final Dividend
8th Feb 20213:59 pmRNSStatement re Offer for Subscription
28th Jan 20214:40 pmRNSStatement re Offer for Subscription
30th Nov 20204:47 pmRNSTransaction in Own Shares
27th Nov 202010:45 amRNSResult of General Meeting
23rd Nov 20205:03 pmRNSTransaction in Own Shares
16th Nov 20204:49 pmRNSTransaction in Own Shares
26th Oct 20207:00 amRNSPublication of a Prospectus
16th Oct 202010:15 amRNSNet Asset Value(s)
28th Aug 202011:27 amRNSDirector/PDMR Shareholding
28th Aug 202010:31 amRNSIssue of Equity
26th Aug 20205:24 pmRNSTransaction in Own Shares
21st Aug 20204:11 pmRNSStatement re NAV and DIS
31st Jul 20207:00 amRNSHolding(s) in Company
29th Jul 20205:11 pmRNSTransaction in Own Shares
29th Jul 202010:55 amRNSHalf-year Report
22nd Jul 20202:25 pmRNSStatement re Intended Joint Offersfor Subscription
16th Jul 20202:38 pmRNSStatement re NAV and Interim Dividend
29th Jun 20202:44 pmRNSDirector Declaration
14th May 20204:47 pmRNSTransaction in Own Shares
29th Apr 20204:36 pmRNSTransaction in Own Shares
28th Apr 202012:12 pmRNSResult of AGM
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:01 pmRNSSuspension of Dividend Investment Scheme (DIS)
19th Mar 20204:30 pmRNSAGM Update – Notification of Change of Venue
11th Mar 20205:23 pmRNSAnnual Financial Report
27th Feb 20203:04 pmRNSTransaction in Own Shares
24th Feb 20203:55 pmRNSTransaction in Own Shares
19th Feb 20204:30 pmRNSTransaction in Own Shares
18th Feb 202011:35 amRNSNet Asset Value and Proposed Final Dividend
28th Jan 20204:53 pmRNSDirectorate Change and Appointment of New Chairman
4th Dec 20199:45 amRNSStatement re Share Premium Account Cancellation
28th Nov 20192:06 pmRNSTransaction in Own Shares
7th Oct 20194:22 pmRNSTransaction in Own Shares
3rd Oct 20192:34 pmRNSNet Asset Value(s)
2nd Sep 20193:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20193:28 pmRNSIssue of Equity
30th Aug 20194:29 pmRNSNet Asset Value(s)
27th Aug 20192:55 pmRNSTransaction in Own Shares
31st Jul 20192:16 pmRNSTransaction in Own Shares
18th Jul 20195:05 pmRNSHalf-year Report
4th Jul 20193:29 pmRNSStatement re Net Asset Value and Interim Dividend
5th Jun 20194:15 pmRNSDirectorate Change
14th May 20192:01 pmRNSTransaction in Own Shares
30th Apr 20191:06 pmRNSResult of AGM
24th Apr 20199:50 amRNSIssue of Equity
4th Apr 20192:16 pmRNSHolding(s) in Company
4th Apr 201911:01 amRNSIssue of Equity - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.